NCT05336786View on ClinicalTrials.gov

Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

May 26, 2025

Study Completion Date

May 26, 2026

Conditions
Prostate Carcinoma
Interventions
DRUG

Perflutren Lipid Microspheres

Given IV

PROCEDURE

Ultrasound

Undergo ultrasound

Trial Locations (2)

19107

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

Unknown

Amsterdam University Medical Centers, Amsterdam

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Thomas Jefferson University

OTHER